NCT00139178View on ClinicalTrials.gov

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

April 30, 2007

Conditions
HIV Associated Lipodystrophy Syndrome.HIVHypercholesterolemiaLipoatrophy
Interventions
DRUG

Different HAART regimens

Trial Locations (4)

2100

Department of Infectious Diseases, Rigshospitalet, Copenhagen

2650

Department of Infectious Diseases, Hvidovre University Hospital, Hvidovre

5000

Department of Infectious diseases, Odense University Hospital, Odense

8200

Department of Infectious Diseases, Aarhus University Hospital, Aarhus

Sponsors
All Listed Sponsors
collaborator

Odense University Hospital

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Hvidovre University Hospital

OTHER

collaborator

Aarhus University Hospital

OTHER

lead

Danish HIV Research Group

OTHER

NCT00139178 - Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir. | Biotech Hunter | Biotech Hunter